204 related articles for article (PubMed ID: 32782133)
21. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
[TBL] [Abstract][Full Text] [Related]
22. Adherence to guideline recommendations for multimodality treatment of patients with pT2-3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes.
Mistretta FA; Negrean-Dzyuba C; Palumbo C; Pecoraro A; Knipper S; Tian Z; Musi G; Montanari E; Perrotte P; Briganti A; Shariat SF; Saad F; de Cobelli O; Karakiewicz PI
Int J Urol; 2020 May; 27(5):402-407. PubMed ID: 32172530
[TBL] [Abstract][Full Text] [Related]
23. Variant histology in upper tract carcinomas: Analysis of the National Cancer Database.
Song E; Suek T; Davaro F; Hamilton Z
Urol Oncol; 2023 Apr; 41(4):206.e1-206.e9. PubMed ID: 36822992
[TBL] [Abstract][Full Text] [Related]
24. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
[TBL] [Abstract][Full Text] [Related]
25. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy.
Campbell RA; Khanna A; Boorjian SA; Knorr J; Cox R; Nicholas M; Cheville J; Sharma V; Murthy PB; Tarrell R; Thapa P; Tollefson MK; Thompson RH; Frank I; Karnes RJ; Haber GP; Lee B
Clin Genitourin Cancer; 2024 Apr; 22(2):157-163.e1. PubMed ID: 38008690
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.
Lonati C; Baumeister P; Ornaghi PI; Di Trapani E; De Cobelli O; Rink M; Karnes RJ; Poyet C; Simone G; Afferi L; Necchi A; Briganti A; Montorsi F; Krajewski W; Antonelli A; Cerruto MA; Zamboni S; Simeone C; Mordasini L; Mattei A; Moschini M;
Eur Urol Focus; 2022 Mar; 8(2):457-464. PubMed ID: 33867307
[TBL] [Abstract][Full Text] [Related]
27. Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients.
Mistretta FA; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Cancer Epidemiol; 2019 Apr; 59():135-142. PubMed ID: 30771698
[TBL] [Abstract][Full Text] [Related]
28. Sociodemographic and survival disparities for histologic variants of bladder cancer.
Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
[TBL] [Abstract][Full Text] [Related]
29. Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer.
Flammia RS; Chierigo F; Würnschimmel C; Wenzel M; Horlemann B; Tian Z; Borghesi M; Leonardo C; Tilki D; Shariat SF; Anceschi U; Chun FKH; Terrone C; Saad F; Gallucci M; Karakiewicz PI
Cent European J Urol; 2022; 75(3):240-247. PubMed ID: 36381153
[TBL] [Abstract][Full Text] [Related]
30. Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.
Moschini M; Shariat SF; Lucianò R; D'Andrea D; Foerster B; Abufaraj M; Bandini M; Dell'Oglio P; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
Clin Genitourin Cancer; 2017 Aug; 15(4):e603-e607. PubMed ID: 28040422
[TBL] [Abstract][Full Text] [Related]
31. Effect of variant histology presence and squamous differentiation on oncological results and patient's survival after radical cystectomy.
Sefik E; Celik S; Basmaci I; Yarımoglu S; Bozkurt IH; Yonguc T; Gunlusoy B
Arch Ital Urol Androl; 2018 Sep; 90(3):172-175. PubMed ID: 30362682
[TBL] [Abstract][Full Text] [Related]
32. Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities.
Cano Garcia C; Piccinelli ML; Tappero S; Panunzio A; Barletta F; Incesu RB; Tian Z; Saad F; Briganti A; Terrone C; Shariat SF; Graefen M; Tilki D; Antonelli A; De Cobelli O; Kosiba M; Banek S; Kluth LA; Chun FKH; Karakiewicz PI
Int Urol Nephrol; 2023 May; 55(5):1117-1123. PubMed ID: 36813873
[TBL] [Abstract][Full Text] [Related]
33. Contemporary 90-day mortality rates after radical cystectomy in the elderly.
Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI
Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826
[TBL] [Abstract][Full Text] [Related]
34. Impact of Divergent Differentiation and/or Histological Subtype of Urothelial Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER Trial.
Allory Y; Culine S; Krucker C; Fontugne J; Harter V; Pfister C
J Urol; 2024 Apr; 211(4):564-574. PubMed ID: 38153961
[TBL] [Abstract][Full Text] [Related]
35. Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis.
Barletta F; Tappero S; Panunzio A; Incesu RB; Cano Garcia C; Piccinelli ML; Tian Z; Gandaglia G; Moschini M; Terrone C; Antonelli A; Tilki D; Chun FKH; De Cobelli O; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Urol Oncol; 2023 Mar; 41(3):147.e1-147.e6. PubMed ID: 36428165
[TBL] [Abstract][Full Text] [Related]
36. Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA.
Zaffuto E; Gazdovich S; Leyh-Bannurah SR; Huland H; Abdollah F; Shariat SF; Menon M; Briganti A; Montorsi F; Karakiewicz PI
Int J Urol; 2017 Feb; 24(2):117-123. PubMed ID: 27875858
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
[TBL] [Abstract][Full Text] [Related]
38. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.
Mazzone E; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Apr; 17(2):105-113.e2. PubMed ID: 30527745
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
[TBL] [Abstract][Full Text] [Related]
40. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]